Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

athenahealth Inc gives FY 2014 guidance below analysts' estimates


Wednesday, 11 Dec 2013 04:01pm EST 

athenahealth Inc:Reaffirms FY 2013 revenue guidance to be in the range of $580-$615 mln.Reaffirms FY 2013 Non-GAAP Adjusted Operating Income to be in the range of $68-$80 mln.Reaffirms FY 2013 Non-GAAP Adjusted Net Income per Diluted Share to be in the range of $1.05-$1.15.Sees FY 2014 revenue guidance to be in the range of $725-$755 mln.Sees FY 2014 Non-GAAP Adjusted Operating Income to be in the range of $70-$80 mln.Sees FY 2014 Non-GAAP Adjusted Net Income per Diluted Share to be in the range of $0.98-$1.10.FY 2013 revenue of $592 mln, FY 2014 EBIT of $69 mln - Thomson Reuters I/B/E/S Estimates.FY 2014 revenue of $765 mln, FY 2014 EBIT of $96 mln, FY 2014 EPS of $1.38 - Thomson Reuters I/B/E/S Estimates. 

Company Quote

145.58
-2.29 -1.55%
17 Apr 2014